Evidence map›Paper›PMID 40207977›Full record

ArticleCell cycle (Georgetown, Tex.)

High GLP1R gene copy numbers associated with microsatellite instability for multiple cancers and with better survival probabilities for glioblastoma.

Teresa M Thomas, Michael T Aboujaoude, Vayda R Barker, Mallika Varkhedi, Rahul Jain, George Blanck

Abstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Teresa M ThomasDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Michael T AboujaoudeDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Vayda R BarkerDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Mallika VarkhediDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Rahul JainDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
George BlanckDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.ORCID 0000-0003-1664-0996

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While the Warburg effect is well-known and frequently studied, the molecular features that facilitate increased tumor cell glycolytic activity have yet to be extensively investigated. We hypothesized that amplification of genes encoding proteins related to glucose metabolism could be a mechanism to facilitate increased glycolysis. Thus, we applied a precision-guided copy number variation analysis approach to the GLP1R, AMFR, GCG, GPI, and ACTA1 genes across three different cancer types. Results indicated that higher CNs of GLP1R in glioblastoma were associated with better patient outcomes, while high CNs of GPI in lower-grade gliomas were associated with worse outcomes. Results also indicated that high microsatellite instability directly correlated with high CNs for most of the above indicated genes. These approaches to assessing tumor metabolism-related genes may lead to more accurate measures of patient risk and potential additional treatment options.

Indexed as

Brain NeoplasmsDNA Copy Number VariationsGene DosageGlioblastomaGlucagon-Like Peptide-1 ReceptorMicrosatellite InstabilityHumansPrognosisGLP1R protein, humanGlucagon-Like Peptide-1 ReceptorCNVglioblastomaGLP1RMSIsensor scoreoverall survival

Identifiers

PMID40207977
PMCPMC12269650

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.